Understanding the Metabolism-immunity Duality of a Glycolytic Inhibitor through Metabolic Imaging to Improve Cancer Immunotherapy in Mice

Our research offers novel perspectives on the application of the glycolytic inhibitor 2DG and emphasizes the significance of radiation-free and non-invasive comprehensive evaluation of glycolysis in the current immunotherapy era.